Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Search content at Johns Hopkins University
Home
Profiles
Research units
Research output
Psychedelics as Medicines: An Emerging New Paradigm
D. E. Nichols
, M. W. Johnson
, C. D. Nichols
School of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
96
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Psychedelics as Medicines: An Emerging New Paradigm'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Psychedelics
100%
Serotonergic Psychedelics
66%
Alcohol
33%
Brain Networks
33%
Tobacco
33%
Addiction
33%
Therapeutic Effect
33%
Inflammatory Diseases
33%
Anti-inflammatory Agents
33%
Anti-inflammatory Effect
33%
Psychotherapy
33%
Unique Mechanism
33%
Acute Effects
33%
Novel Mechanism
33%
Global Network
33%
Inpatient Treatment
33%
Network Connectivity
33%
5-HT2A Receptor Agonist
33%
Hub Networks
33%
Neuronal Avalanches
33%
Psilocybin
33%
Inflammation-related Diseases
33%
Brain Network Hubs
33%
Nonpsychotic Mental Disorders
33%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Clinical Study
100%
Therapeutic Effect
100%
Antiinflammatory Agent
100%
Inflammatory Disease
100%
Receptor Agonist
100%
Psilocybin
100%
Medicine and Dentistry
Neurodevelopmental Disorder
100%
Addictive Behavior
50%
Receptor
50%
Clinical Study
50%
Therapy Effect
50%
Inflammatory Disorder
50%
Antiinflammatory Agent
50%
Psilocybine
50%
Antiinflammatory Activity
50%
Inflammation
50%
Neuroscience
Brain Network
100%
Mental Disorder
100%
Serotonergic Psychedelic
100%
Receptor Agonists
50%
5-HT2A Receptor
50%
Psilocybin
50%